Nikhil Pathak

Title: Nikhil Pathak: Innovator in SARS-CoV-2 Treatment

Introduction

Nikhil Pathak is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical science, particularly in the fight against viral infections. His innovative approach to treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has garnered attention in the scientific community.

Latest Patents

Nikhil Pathak holds a patent for a method against SARS-CoV-2 infection. The patent discloses a method that includes administering a first active ingredient, which can be methotrexate (MIX) or a pharmaceutically acceptable salt thereof. Additionally, a second active ingredient is selected from remdesivir or a pharmaceutically acceptable salt thereof. The method specifies a molar ratio of the first active ingredient to the second active ingredient ranging from 1:13 to 1:25. This innovative treatment approach aims to provide effective solutions for those affected by the virus.

Career Highlights

Nikhil Pathak is affiliated with National Yang Ming Chiao Tung University, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing pressing health challenges through innovative solutions. With a focus on viral infections, he has positioned himself as a key figure in the field of medical research.

Collaborations

Nikhil collaborates with esteemed colleagues, including Jinn-Moon Yang and Yen-Chao Hsu. These partnerships enhance the research efforts and contribute to the development of effective treatments for viral infections.

Conclusion

Nikhil Pathak's contributions to the field of medical science, particularly in the treatment of SARS-CoV-2, highlight his innovative spirit and dedication to improving public health. His patent and ongoing research efforts reflect a commitment to finding effective solutions for critical health issues.